[HTML][HTML] Advances in understanding N-glycosylation structure, function, and regulation in health and disease

S Esmail, MF Manolson - European journal of cell biology, 2021 - Elsevier
N-linked glycosylation is a post-translational modification crucial for membrane protein
folding, stability and other cellular functions. Alteration of membrane protein N-glycans is …

Yarrowia lipolytica Strains and Their Biotechnological Applications: How Natural Biodiversity and Metabolic Engineering Could Contribute to Cell Factories …

C Madzak - Journal of Fungi, 2021 - mdpi.com
Among non-conventional yeasts of industrial interest, the dimorphic oleaginous yeast
Yarrowia lipolytica appears as one of the most attractive for a large range of white …

Glyco-Decipher enables glycan database-independent peptide matching and in-depth characterization of site-specific N-glycosylation

Z Fang, H Qin, J Mao, Z Wang, N Zhang… - Nature …, 2022 - nature.com
Glycopeptides with unusual glycans or poor peptide backbone fragmentation in tandem
mass spectrometry are unaccounted for in typical site-specific glycoproteomics analysis and …

Lysosomal storage diseases: from pathophysiology to therapy

G Parenti, G Andria, A Ballabio - Annual review of medicine, 2015 - annualreviews.org
Lysosomal storage diseases are a group of rare, inborn, metabolic errors characterized by
deficiencies in normal lysosomal function and by intralysosomal accumulation of …

Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up

A Madhavan, KB Arun, R Sindhu… - Microbial Cell …, 2021 - Springer
The manufacture of recombinant therapeutics is a fastest-developing section of therapeutic
pharmaceuticals and presently plays a significant role in disease management. Yeasts are …

Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease

C Spampanato, E Feeney, L Li, M Cardone… - EMBO molecular …, 2013 - embopress.org
A recently proposed therapeutic approach for lysosomal storage disorders (LSDs) relies
upon the ability of transcription factor EB (TFEB) to stimulate autophagy and induce …

Biotechnological applications of Yarrowia lipolytica: past, present and future

HH Liu, XJ Ji, H Huang - Biotechnology Advances, 2015 - Elsevier
Non-conventional yeasts have attracted increasing interest due to their biochemical
characteristics and potential applications. Yarrowia lipolytica is a non-conventional yeast …

Yarrowia lipolytica: recent achievements in heterologous protein expression and pathway engineering

C Madzak - Applied microbiology and biotechnology, 2015 - Springer
The oleaginous yeast Yarrowia lipolytica has become a recognized system for
expression/secretion of heterologous proteins. This non-conventional yeast is currently …

[HTML][HTML] Implementing CRISPR-Cas technologies in conventional and non-conventional yeasts: Current state and future prospects

H Raschmanová, A Weninger, A Glieder, K Kovar… - Biotechnology …, 2018 - Elsevier
Within five years, the CRISPR-Cas system has emerged as the dominating tool for genome
engineering, while also changing the speed and efficiency of metabolic engineering in …

A guide into glycosciences: how chemistry, biochemistry and biology cooperate to crack the sugar code

D Solis, NV Bovin, AP Davis, J Jiménez-Barbero… - … et Biophysica Acta (BBA …, 2015 - Elsevier
Background The most demanding challenge in research on molecular aspects within the
flow of biological information is posed by the complex carbohydrates (glycan part of cellular …